COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n

Updated on: April 13,2024 13

COVID infection may boost antibodies for up to 20 months

If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.While this is reassuring, experts are quick to caution that the new findings don't n

Updated on:April 13,2024 13

Does body mass index impact pain in individuals with hand osteoarthritis?

by WileyCredit: Unsplash/CC0 Public DomainIn a study inArthritis & Rheumatologyof people with hand osteoarthritis, higher body mass index was associated with greater pain severity

Updated on: June 15,2024 5

Does body mass index impact pain in individuals with hand osteoarthritis?

by WileyCredit: Unsplash/CC0 Public DomainIn a study inArthritis & Rheumatologyof people with hand osteoarthritis, higher body mass index was associated with greater pain severity

Updated on:June 15,2024 5

Omega 3 fatty acids may reduce bacterial lung infections associated with COPD

by Suzanne Pallo,University of Rochester Medical CenterCompounds derived from omega-3 fatty acids – like those found in salmon – might be the key to helping the body combat lung infections, acco

Updated on: April 20,2024 15

Omega 3 fatty acids may reduce bacterial lung infections associated with COPD

by Suzanne Pallo,University of Rochester Medical CenterCompounds derived from omega-3 fatty acids – like those found in salmon – might be the key to helping the body combat lung infections, acco

Updated on:April 20,2024 15

Depemokimab cuts exacerbation rate in eosinophilic asthma

by Elana GotkineFor patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, according to a studypublishedonline Sept. 9 in the

Updated on: October 01,2024 0

Depemokimab cuts exacerbation rate in eosinophilic asthma

by Elana GotkineFor patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, according to a studypublishedonline Sept. 9 in the

Updated on:October 01,2024 0

Antibacterial material restores the efficacy of antibiotics against resistant bacteria

byChalmers University of TechnologyThe antibacterial material is a proprietary hydrogel, which can be adapted to many medical applications. Credit: Saba AtefyektaResearch from Chalmers Universit

Updated on: November 21,2024 0

Antibacterial material restores the efficacy of antibiotics against resistant bacteria

byChalmers University of TechnologyThe antibacterial material is a proprietary hydrogel, which can be adapted to many medical applications. Credit: Saba AtefyektaResearch from Chalmers Universit

Updated on:November 21,2024 0

Lab-created molecule achieves positive results in the treatment of arthritis

by FAPESPArthritic mouse paw treated with TPPU (left) and untreated paw of another arthritic mouse. The substance decreased the area affected, reduced local swelling, and assuaged the pain associ

Updated on: March 24,2024 18

Lab-created molecule achieves positive results in the treatment of arthritis

by FAPESPArthritic mouse paw treated with TPPU (left) and untreated paw of another arthritic mouse. The substance decreased the area affected, reduced local swelling, and assuaged the pain associ

Updated on:March 24,2024 18

Unusual type of antibody shows ultrapotent activity against Zika

by Weill Cornell Medical CollegeZika virus particles (red) shown in African green monkey kidney cells. Credit: NIAIDAn unusual type of antibody that even at miniscule levels neutralizes the Zika

Updated on: May 07,2024 12

Unusual type of antibody shows ultrapotent activity against Zika

by Weill Cornell Medical CollegeZika virus particles (red) shown in African green monkey kidney cells. Credit: NIAIDAn unusual type of antibody that even at miniscule levels neutralizes the Zika

Updated on:May 07,2024 12

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants

by La Jolla Institute for ImmunologyT cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-Co

Updated on: April 20,2024 20

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants

by La Jolla Institute for ImmunologyT cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-Co

Updated on:April 20,2024 20

T cells: Vesicles strengthen immune response

by Ludwig Maximilian University of MunichMFG-E8-eGFP detects PS+ apoptotic and PS+ EV-decorated cells in vivo. Credit: Proceedings of the National Academy of Sciences (2023). DOI: 10.1073/pnas.22

Updated on: May 05,2024 14

T cells: Vesicles strengthen immune response

by Ludwig Maximilian University of MunichMFG-E8-eGFP detects PS+ apoptotic and PS+ EV-decorated cells in vivo. Credit: Proceedings of the National Academy of Sciences (2023). DOI: 10.1073/pnas.22

Updated on:May 05,2024 14

New drug expands treatment opportunities for rheumatoid arthritis

by Medical University of ViennaCredit: Unsplash/CC0 Public DomainIn its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the

Updated on: June 26,2024 8

New drug expands treatment opportunities for rheumatoid arthritis

by Medical University of ViennaCredit: Unsplash/CC0 Public DomainIn its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the

Updated on:June 26,2024 8

Sleep problems not a major issue in rheumatoid arthritis

Sleep problems are not excessive in patients with newly diagnosed rheumatoid arthritis, according to a study recently published inRMD Open.Lauren Lyne, from the Karolinska Institutet in Stockhol

Updated on: May 29,2024 6

Sleep problems not a major issue in rheumatoid arthritis

Sleep problems are not excessive in patients with newly diagnosed rheumatoid arthritis, according to a study recently published inRMD Open.Lauren Lyne, from the Karolinska Institutet in Stockhol

Updated on:May 29,2024 6

Moms with systemic lupus erythematosus at double the risk of having premature or growth-restricted babies, finds study

by British Medical JournalCredit: Unsplash/CC0 Public DomainMothers with the long term autoimmune disorder, systemic lupus erythematosus, or SLE for short, run more than double the risk of giving

Updated on: June 05,2024 4

Moms with systemic lupus erythematosus at double the risk of having premature or growth-restricted babies, finds study

by British Medical JournalCredit: Unsplash/CC0 Public DomainMothers with the long term autoimmune disorder, systemic lupus erythematosus, or SLE for short, run more than double the risk of giving

Updated on:June 05,2024 4